The Wilms tumor 1 (WT1) protein is an immunogenic tumor-associated antigen that is over-expressed in CD34 + MDS stem cells and AML blasts which elicits T-cell mediated myelosuppression and is a candidate antigen for vaccine therapy [130,141]. This evidence concerns the gene WT1 and acute myeloid leukemia.